Abstract
Reply to comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.
Highlights
We welcome the comment by Feller and colleagues [1] about our study on ovarian cancer epidemiology and treatment in Switzerland [2]
We identified incident ovarian cancer patients based on a C56 main diagnosis and by applying a preceding ovarian cancer event-free period of 6 years
In comparison with data of the National Institute for Cancer Epidemiology and Registration (NICER), we found a similar slight decline in age-adjusted incidence of ovarian cancer between 2004 and 2012, but at a substantially higher level (+35%)
Summary
We welcome the comment by Feller and colleagues [1] about our study on ovarian cancer epidemiology and treatment in Switzerland [2]. Their comment contributes to a much-needed discussion on the strengths and limitations of the various data sources available for epidemiological research in Switzerland. Our study estimated the incidence of ovarian cancer based on a hospital registry covering all inpatient care episodes.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
